Therefore, considering that somatic mutations of FOXP3 are common in human breast cancer tissues, it is usually thought that the cytoplasmic localization of FOXP3, resulting from somatic mutation, is associated with the loss of its tumor-suppressive function11,32. This evidence concerns the gene FOXP3 and breast cancer.